Bayer HealthCare Pharmaceuticals Has Selected Biologics, Inc. (NC) As A Limited Distribution Network Provider For NEXAVAR (Sorafenib) And STIVARGA (Regorafenib)

CARY, N.C.--(BUSINESS WIRE)--Biologics, an integrated oncology services company, is pleased to announce that Bayer HealthCare Pharmaceuticals, Inc. has selected the company to be a limited distribution network provider for two leading oncology medications, NEXAVAR® (sorafenib) and STIVARGA® (regorafenib).

Help employers find you! Check out all the jobs and post your resume.